Q&A: Horizon’s commercial chief Keli Walbert talks Tepezza, rare disease marketing and family ties
Keli Walbert joined Horizon Therapeutics a few years ago at the urging of former colleagues who worked there – not her husband, Tim Walbert, who happens to be the CEO.
Not that he didn’t want her to join, but for Keli, the decision came with careful consideration about how it might affect their family, which includes four children. Especially when it came to heading up the launch of Tepezza in early 2020.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.